Back to Agenda
People Will Talk: Gathering Insights from Digital Listening
Session Chair(s)
Lorrie Schifano, PharmD
Director, Global Clinical Safety and Pharmacovigilance
GlaxoSmithKline, United States
There is growing interest from global stakeholders — biopharma, regulators, and patients — to analyze digital health information either posted online by patients or captured by pharma through patient/HCP requests. This information represents a large repository of safety and patient experience insights that could supplement data from existing sources. Panelists in this DIAmond session will address how digital health information can be analyzed to support medical affairs, pharmacovigilance and commercialization efforts. Topics addressed include an overview of techniques, use cases, compliance with regulatory guidelines, and patient privacy.
Learning Objective : Describe the challenges of using social media data to supplement postmarketing safety data; Discuss the impact of social media data on compliance with regulatory guidelines.
Speaker(s)
Current Techniques for Analyzing Text That Can be Used in Medical Affairs, Benefit-Risk Assessment, and the Voice of the Customer
Jeffery Lanier Painter, JD, MS
GlaxoSmithKline, United States
Safety and Quanitative Innovation Leader
Digital Listening Throughout a Product's Life Cycle
Chi Bahk, MS
Booz Allen Hamilton, United States
Business Operations Lead, Epidemico
Current Parameters for Collecting/Utilizing This Data Compliantly
Phil Tregunno
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Deputy Director - Patient Safety Monitoring
Panelist
Gerald Dal Pan, MD, MHS
FDA, United States
Director, Office of Surveillance and Epidemiology, CDER
Have an account?